Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  SK Chemicals Co.,Ltd.    A285130   KR7285130001

SK CHEMICALS CO.,LTD.

(A285130)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SK Chemicals : South Korea's SK Bioscience in deal with AstraZeneca on vaccine

07/21/2020 | 07:19am EST
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York

South Korea's SK Bioscience has agreed to manufacture AstraZeneca's experimental COVID-19 vaccine to help the British company build global supplies of the vaccine that has shown promise against the new coronavirus, it said on Tuesday.

Data on Monday showed that the vaccine, jointly developed by AstraZeneca and the University of Oxford, produced an immune response in early-stage clinical trials.

AstraZeneca has signed agreements with governments around the world to supply the vaccine should it prove effective and gain regulatory approval. It has already signed deals to produce and supply over 2 billion doses of the shot, with 300 million doses earmarked for the United States.

SK Bioscience, a unit of SK Chemicals, said it will start producing undiluted solutions of the vaccine after discussing production plans with AstraZeneca.

The manufacturing contract, which begins this month, will last until early next year and could be extended depending on AstraZeneca's success in development of the vaccine, SK said.

South Korea's health ministry arranged discussions between the two companies and will also begin discussions with AstraZeneca to introduce the vaccine to the country, it said.

The World Health Organization's chief scientist has said the vaccine, called AZD1222, is the leading candidate in a global race to halt a pandemic that has killed more than 600,000.

AZD1222 was developed by Oxford University and licensed to AstraZeneca, which has put it into large-scale, late-stage trials to test its efficacy.

(Reporting by Sangmi Cha; Editing by Jason Neely and Tom Hogue)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.78% 7722 Delayed Quote.4.62%
SK CHEMICALS CO.,LTD. 4.26% 392000 End-of-day quote.-0.13%
All news about SK CHEMICALS CO.,LTD.
2020Vaccine developer SK Bioscience targets IPO in first half of 2021
RE
2020MARKET CHATTER : SK Chemicals Stock Moves up on Third Quarter Results
MT
2020South Korea to secure coronavirus vaccines for 60% of population
RE
2020SK CHEMICALS : South Korea's SK Bioscience in deal with AstraZeneca on vaccine
RE
2020ASTRAZENECA : S.Korea's SK Bioscience in deal with AstraZeneca on vaccine
RE
2020ASTRAZENECA : South Korea's SK Bioscience in deal with AstraZeneca on vaccine
RE
2020SK CHEMICALS : Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Cli..
AQ
2019Global refiners raise cleaner shipping fuel output ahead of IMO 2020
RE
2018SK CHEMICALS : Entering Auto Parts Market with Next-gen PPS
BU
More news
Financials
Sales 2020 1 348 B 1,22 B 1,22 B
Net income 2020 348 B 0,32 B 0,32 B
Net Debt 2020 349 B 0,32 B 0,32 B
P/E ratio 2020 22,6x
Yield 2020 0,11%
Capitalization 4 824 B 4 366 M 4 380 M
EV / Sales 2020 3 579x
EV / Sales 2021 3 167x
Nbr of Employees -
Free-Float 68,0%
Chart SK CHEMICALS CO.,LTD.
Duration : Period :
SK Chemicals Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SK CHEMICALS CO.,LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 437 500,00 KRW
Last Close Price 392 000,00 KRW
Spread / Highest target 37,8%
Spread / Average Target 11,6%
Spread / Lowest Target -33,7%
EPS Revisions
Managers and Directors
NameTitle
Cheol Kim Co-President, Co-CEO & Director
Gwang-Hyun Jeon Co-President, Co-CEO & Director
Jong-Ryang Kim Head-Research Institute
Jeong-Hwan Choi Independent Director
Yang-Ho Ahn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SK CHEMICALS CO.,LTD.-0.13%4 192
LG CHEM, LTD.16.99%63 925
DOW INC.3.26%42 510
FORMOSA PLASTICS CORPORATION-3.42%21 168
FORMOSA CHEMICALS & FIBRE CORPORATION-3.07%17 152
COVESTRO AG9.03%12 834